← Leaderboards
Dominic S Raj
University Of New Mexico
$8,434,404
Attributed
$8,434,404
Total exposure
9
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $751.4K · FY2005–23$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$8,434,404 · 9
By mechanism
R01$4,546,428 · 2
U01$3,629,945 · 2
R21$183,609 · 1
M01$74,422 · 4
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “End Stage Renal Failure”
- Harold I Feldman · University Of Pennsylvania$59,348,508
- Peter Scott Heeger · Case Western Reserve University$53,226,767
- David Reboussin · Wake Forest University Health Sciences$26,702,221
- Ali G Gharavi · Mount Sinai School Of Medicine Of Nyu$22,349,935
- Alessandro Doria · Joslin Diabetes Center$22,059,754
- S Michael Mauer · University Of Minnesota Twin Cities$20,188,220
Research focus
End Stage Renal FailureParticipantKidneyPlasmaChronic Kidney FailureCytokineInflammationFollow-UpInflammatoryLinkCardiovascular DiseasesProteinuriaRenal FunctionKidney DiseasesPrevalenceEtiologyAtherosclerosisGenerationsEndotoxinsColonFoodImaging TechniquesAnti-InflammatoryEquilibrium
Grant awards (26)
Non-Coding RNA and CKD Progression$368,918
R01 · FY2023 · DK · contact PI
Non-Coding RNA and CKD Progression$528,612
R01 · FY2022 · DK · contact PI
Non-Coding RNA and CKD Progression$678,525
R01 · FY2021 · DK · contact PI
Non-Coding RNA and CKD Progression$712,582
R01 · FY2020 · DK · contact PI
Anti-inflammatory Therapy in Diabetic CKD$1,000
U01 · FY2018 · DK · contact PI
Gut Microbiota and Atherosclerosis in ESRD$368,337
U01 · FY2017 · DK · contact PI
Anti-inflammatory Therapy in Diabetic CKD$340,630
U01 · FY2017 · DK · contact PI
Gut Microbiota and Atherosclerosis in ESRD$364,279
U01 · FY2016 · DK · contact PI
Anti-inflammatory Therapy in Diabetic CKD$344,394
U01 · FY2016 · DK · contact PI
Gut Microbiota and Atherosclerosis in ESRD$365,304
U01 · FY2015 · DK · contact PI
Anti-inflammatory Therapy in Diabetic CKD$356,745
U01 · FY2015 · DK · contact PI
Gut Microbiota and Atherosclerosis in ESRD$385,000
U01 · FY2014 · DK · contact PI
Anti-inflammatory Therapy in Diabetic CKD$366,407
U01 · FY2014 · DK · contact PI
Gut Microbiota and Atherosclerosis in ESRD$385,000
U01 · FY2013 · DK · contact PI
Anti-inflammatory Therapy in Diabetic CKD$352,849
U01 · FY2013 · DK · contact PI
Cytokine Gene Polymorphism in CRIC Cohort$529,879
R01 · FY2010 · DK · contact PI
Cytokine Gene Polymorphism in CRIC Cohort$458,660
R01 · FY2009 · DK · contact PI
Cytokine Gene Polymorphism in CRIC Cohort$407,244
R01 · FY2008 · DK · contact PI
CYTOKINE ACTIVATION AND PROTEIN CATABOLISM IN ESRD$30,527
M01 · FY2008 · RR · contact PI
Cytokine Gene Polymorphism in CRIC Cohort$411,325
R01 · FY2007 · DK · contact PI
Cytokine Gene Polymorphism in CRIC Cohort$450,683
R01 · FY2006 · DK · contact PI
OXIDATIVE STRESS, MITOCHONDRIAL DNA DAMAGE & SARCOPENIA$14,845
M01 · FY2006 · RR · contact PI
Mitochondrial Function and mtDNA Deletions in Sarcopenia$33,609
R21 · FY2005 · AG
Mitochondrial Function and mtDNA Deletions in Sarcopenia$150,000
R21 · FY2004 · AG
Protein Turnover and Amino Acid Transport Kinetics$23,464
M01 · FY2004 · RR
Hemodialysis on Protein Turn Over and Amino Acids$5,586
M01 · FY2004 · RR